Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917579856> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2917579856 endingPage "S112" @default.
- W2917579856 startingPage "S112" @default.
- W2917579856 abstract "Splenic artery aneurysm is a rare entity. Embolization is the treatment of choice. We aim to evaluate the outcomes of embolization for the treatment of splenic artery aneurysms in cirrhotic and non-cirrhotic patients From 2008 to 2017, all patients who underwent embolization for splenic arterial aneurysms were included in this IRB-approved retrospective review. Treatment technique was studied. Outcomes included complications, 30-day leukocytosis, liver function tests, and platelet counts. Univariate logistic regression analyses were performed to compare laboratory values pre- and post-embolization. Substratification analyses based on presence and absence of cirrhosis were performed (serious adverse events among cirrhotic/non-cirrhotic patients were compared using Fischer’s test). 30 patients (7 males, mean age 52 [range:37-75]) were included. 20 (66%) splenic artery aneurysms were incidentally detected on imaging; 10 (33%) patients had concurrent cirrhosis. Post-embolization, patients had median length of hospitalization of 1 day (CI:0-2). Within 30 days, 12 (40%) patients had post-embolization leukocytosis (median of 22,000/μl). 26 (87%) of aneurysms were located distal to the origin of the dorsal pancreatic artery branches; no patients had post-embolization pancreatitis. 30-day post-embolization platelet count increase in cirrhotic vs. non-cirrhotic patients was 90×103/μl (CI: 55-124) and 225×103/μl (CI: 23-428) (p=0.015). Cirrhotic patients had higher incidence of hilar aneurysms (80%) than non-cirrhotic patients (60%) (p=0.4). Greather than 50% splenic infarction rate was higher in cirrhotics (50%) vs. non-cirrhotics (15%) (p=0.08). Rate of serious adverse events (sepsis due to spontaneous bacterial peritonitis/empyema or death) was higher in the cirrhotic (66%) vs non-cirrhotic (0%) patients (p=0.003). Splenic artery aneurysm embolization can be performed safely in non-cirrhotic patients. There is a significantly higher serious adverse event rate in cirrhotic vs. non-cirrhotic patients. We recommend caution in treating splenic artery aneurysms in cirrhotic patients." @default.
- W2917579856 created "2019-03-02" @default.
- W2917579856 creator A5011003738 @default.
- W2917579856 creator A5033464248 @default.
- W2917579856 creator A5046493917 @default.
- W2917579856 creator A5075153200 @default.
- W2917579856 creator A5086297355 @default.
- W2917579856 creator A5087536545 @default.
- W2917579856 creator A5090820066 @default.
- W2917579856 date "2019-03-01" @default.
- W2917579856 modified "2023-09-25" @default.
- W2917579856 title "03:27 PM Abstract No. 251 Post-embolization outcomes of splenic artery aneurysms in cirrhotic and non-cirrhotic patients" @default.
- W2917579856 doi "https://doi.org/10.1016/j.jvir.2018.12.312" @default.
- W2917579856 hasPublicationYear "2019" @default.
- W2917579856 type Work @default.
- W2917579856 sameAs 2917579856 @default.
- W2917579856 citedByCount "0" @default.
- W2917579856 crossrefType "journal-article" @default.
- W2917579856 hasAuthorship W2917579856A5011003738 @default.
- W2917579856 hasAuthorship W2917579856A5033464248 @default.
- W2917579856 hasAuthorship W2917579856A5046493917 @default.
- W2917579856 hasAuthorship W2917579856A5075153200 @default.
- W2917579856 hasAuthorship W2917579856A5086297355 @default.
- W2917579856 hasAuthorship W2917579856A5087536545 @default.
- W2917579856 hasAuthorship W2917579856A5090820066 @default.
- W2917579856 hasBestOaLocation W29175798561 @default.
- W2917579856 hasConcept C126322002 @default.
- W2917579856 hasConcept C126838900 @default.
- W2917579856 hasConcept C141071460 @default.
- W2917579856 hasConcept C2776035437 @default.
- W2917579856 hasConcept C2777214474 @default.
- W2917579856 hasConcept C2778923028 @default.
- W2917579856 hasConcept C2780333324 @default.
- W2917579856 hasConcept C2780931953 @default.
- W2917579856 hasConcept C2781214320 @default.
- W2917579856 hasConcept C71924100 @default.
- W2917579856 hasConcept C90924648 @default.
- W2917579856 hasConceptScore W2917579856C126322002 @default.
- W2917579856 hasConceptScore W2917579856C126838900 @default.
- W2917579856 hasConceptScore W2917579856C141071460 @default.
- W2917579856 hasConceptScore W2917579856C2776035437 @default.
- W2917579856 hasConceptScore W2917579856C2777214474 @default.
- W2917579856 hasConceptScore W2917579856C2778923028 @default.
- W2917579856 hasConceptScore W2917579856C2780333324 @default.
- W2917579856 hasConceptScore W2917579856C2780931953 @default.
- W2917579856 hasConceptScore W2917579856C2781214320 @default.
- W2917579856 hasConceptScore W2917579856C71924100 @default.
- W2917579856 hasConceptScore W2917579856C90924648 @default.
- W2917579856 hasIssue "3" @default.
- W2917579856 hasLocation W29175798561 @default.
- W2917579856 hasOpenAccess W2917579856 @default.
- W2917579856 hasPrimaryLocation W29175798561 @default.
- W2917579856 hasRelatedWork W1980900142 @default.
- W2917579856 hasRelatedWork W2070501940 @default.
- W2917579856 hasRelatedWork W2318208533 @default.
- W2917579856 hasRelatedWork W2358106815 @default.
- W2917579856 hasRelatedWork W2414128218 @default.
- W2917579856 hasRelatedWork W2461917350 @default.
- W2917579856 hasRelatedWork W3087072634 @default.
- W2917579856 hasRelatedWork W3108875615 @default.
- W2917579856 hasRelatedWork W3183349584 @default.
- W2917579856 hasRelatedWork W4293510896 @default.
- W2917579856 hasVolume "30" @default.
- W2917579856 isParatext "false" @default.
- W2917579856 isRetracted "false" @default.
- W2917579856 magId "2917579856" @default.
- W2917579856 workType "article" @default.